glutamine has been researched along with Leukemia, Lymphoblastic, Acute, T Cell in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 3 (60.00) | 2.80 |
| Authors | Studies |
|---|---|
| Al-Atrash, G; Andreeff, M; Baran, N; Cavazos, A; Collins, M; Daher, M; Dhungana, Y; Du, D; Emilia Di Francesco, M; Eric Davis, R; Feng, N; Ferrando, A; Furudate, K; Gagea, M; Garcia, LM; Gareau, Y; Gay, J; Haman, A; Harutyunyan, K; Herbrich, S; Herranz, D; Hoang, T; Hoff, FW; Horton, TM; Jabbour, EJ; Kaminski, M; Kaplan, M; Konopleva, M; Kornblau, S; Kuruvilla, VM; Lodi, A; Lorenzi, PL; Ma, H; Marinier, A; Marszalek, JR; Pandey, R; Patel, S; Piya, S; Rezvani, K; Rojas-Sutterin, S; Ruvolo, V; Sauvageau, G; Shanmugavelandy, SS; Skwarska, A; Sweeney, S; Takahashi, K; Teachey, DT; Tiziani, S; Tomczak, K; Tremblay, M; Veiga, DT; Warmoes, MO; Yang, JJ; Yang, W; Yu, J | 1 |
| Aguilar, E; Alves-Guerra, MC; Bertho, G; Caradeuc, C; Croyal, M; Dentin, R; Lenoir, V; Luby, A; Pecqueur, C; Postic, C; Prip-Buus, C; Ransy, C; Renoult, O; Sancerni, T | 1 |
| Hu, J; Jiang, J; Li, P; Liu, H; Liu, Y; Qing, G; Su, H; Wang, D; Wang, J; Wang, L; Wang, T; Wu, S; Xu, J; Yue, M; Zhou, F | 1 |
| Antanasijevic, A; Bosland, MC; Caffrey, M; De Moerloose, B; Goossens, S; Kabirov, KK; Kajdacsy-Balla, A; Lammens, T; Lavie, A; Liu, L; Lyubimov, AV; Mahmud, DL; Merrill, BJ; Mondelaers, V; Nguyen, HA; Oh, A; Peirs, S; Rondelli, D; Saunthararajah, Y; Schalk, AM; Schlicht, MJ; Su, Y; Van Vlierberghe, P; Zhang, JY | 1 |
| Ambesi-Impiombato, A; Belver, L; Castillo, M; Cordon-Cardo, C; DeBerardinis, RJ; Ferrando, AA; Haydu, JE; Herranz, D; Kung, AL; Márquez, J; Matés, JM; Rayport, S; Sánchez-Martín, M; Sudderth, J; Tosello, V; Wendorff, AA; Xu, L | 1 |
5 other study(ies) available for glutamine and Leukemia, Lymphoblastic, Acute, T Cell
| Article | Year |
|---|---|
Inhibition of mitochondrial complex I reverses NOTCH1-driven metabolic reprogramming in T-cell acute lymphoblastic leukemia.
Topics: Animals; Electron Transport Complex I; Glutamine; Mice; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Receptor, Notch1; T-Lymphocytes | 2022 |
UCP2 silencing restrains leukemia cell proliferation through glutamine metabolic remodeling.
Topics: Cell Proliferation; Glutamine; Humans; Lipids; Malates; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Tricarboxylic Acids; Uncoupling Protein 2 | 2022 |
WEE1 inhibition induces glutamine addiction in T-cell acute lymphoblastic leukemia.
Topics: Apoptosis; Cell Cycle Proteins; Cell Line, Tumor; Glutamine; Humans; Nuclear Proteins; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Protein-Tyrosine Kinases | 2021 |
A Novel l-Asparaginase with low l-Glutaminase Coactivity Is Highly Efficacious against Both T- and B-cell Acute Lymphoblastic Leukemias
Topics: Animals; Antineoplastic Agents; Asparaginase; Cell Line, Tumor; Female; Glutaminase; Glutamine; Humans; Male; Mice, Inbred C57BL; Mice, SCID; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Recombinant Proteins; Toxicity Tests, Acute; Xenograft Model Antitumor Assays | 2018 |
Metabolic reprogramming induces resistance to anti-NOTCH1 therapies in T cell acute lymphoblastic leukemia.
Topics: Animals; Antineoplastic Agents; Drug Resistance, Neoplasm; Glutamine; Mice; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Receptor, Notch1 | 2015 |